Mind Medicine (MindMed) Inc. financial data

Symbol
MNMD on Nasdaq
Location
One World Trade Center, Suite 8500, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 526 % +0.17%
Debt-to-equity 38.4 % +13.5%
Return On Equity -86.2 % -62.7%
Return On Assets -62.3 % -57.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 98.5M shares +34.3%
Common Stock, Shares, Outstanding 76.8M shares -5.9%
Entity Public Float 515M USD +268%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 85.9M shares +10.2%
Weighted Average Number of Shares Outstanding, Diluted 85.9M shares +7.04%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 106M USD +92.3%
General and Administrative Expense 45.3M USD +17.4%
Operating Income (Loss) -151M USD -61.4%
Net Income (Loss) Attributable to Parent -168M USD -71.9%
Earnings Per Share, Basic -1 USD/shares +14.6%
Earnings Per Share, Diluted -1 USD/shares +33.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20M USD -93.2%
Assets, Current 216M USD -27.9%
Operating Lease, Right-of-Use Asset 600K USD
Goodwill 19.9M USD 0%
Other Assets, Noncurrent 1.15M USD +133%
Assets 237M USD -25.9%
Accounts Payable, Current 8.11M USD +278%
Accrued Liabilities, Current 19M USD +116%
Liabilities, Current 65.4M USD +96.7%
Other Liabilities, Noncurrent 519K USD
Liabilities 106M USD +84.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1M USD +21.9%
Retained Earnings (Accumulated Deficit) -532M USD -46.2%
Stockholders' Equity Attributable to Parent 131M USD -50.2%
Liabilities and Equity 237M USD -25.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.4M USD -77.2%
Net Cash Provided by (Used in) Financing Activities 1M USD -99.4%
Net Cash Provided by (Used in) Investing Activities -162M USD
Common Stock, Shares, Issued 76.8M shares -5.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -191M USD -225%
Interest Paid, Excluding Capitalized Interest, Operating Activities 602K USD +38.7%
Deferred Tax Assets, Valuation Allowance 69.9M USD +37%
Operating Lease, Liability 600K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -168M USD -71.8%
Deferred Tax Assets, Operating Loss Carryforwards 42.5M USD +34.6%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 900K USD
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 18.4M USD +13%
Interest Expense 4.87M USD +136%